All In MedTech

Device Trial Radar · NCT03947619

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

Last checked: Nov 21, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 527 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

527

Actual

Start

Dec 12, 2019

Primary completion

Sep 4, 2024

Study completion Oct 2030

Sponsor

Lead sponsor
Abiomed Inc.Public (JNJ)
Sponsor type
Industry
First posted
May 13, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Factorial
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior to a catheterization procedure has the potential to reduce the damage to the heart caused by a heart attack, compared to the current standard of care.

Conditions

  • ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

Interventions

  • Impella CP® placement prior to reperfusion with Primary PCIDevice

    Subjects randomized to the experimental arm, will undergo Impella CP® placement through a femoral arterial sheath and the Impella device will be activated to unload the left ventricle.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Infarct SizeTime frame: 3-5 days post-procedure

Locations

63 sites in 6 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

62 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.